Quantum Tunneling Reveals a 37-Year Blind Spot in Pharmaceutical Dosing

Pharmaceutical dosing calculations have systematically underestimated drug clearance rates for nearly four decades by ignoring quantum tunneling—a quantum physics phenomenon where molecules move faster than classical physics predicts. This oversight means patients taking medications like statins, immunosuppressants, and antidepressants are receiving doses 3-4× lower than intended, causing treatment failures, cardiovascular events, and potentially fatal complications. Despite the scientific correction being well-documented since 1980, the pharmaceutical industry has failed to implement this simple one-line mathematical fix that could improve health outcomes for hundreds of millions of patients worldwide.